Forma Therapeutics Holdings Inc
NASDAQ:FMTX
Cash Flow Statement
Cash Flow Statement
Forma Therapeutics Holdings Inc
Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||
Net Income |
(59)
|
(70)
|
(97)
|
(70)
|
(118)
|
(136)
|
(151)
|
(173)
|
(181)
|
(190)
|
|
Depreciation & Amortization |
2
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
|
Other Non-Cash Items |
(22)
|
(19)
|
(17)
|
(16)
|
11
|
15
|
20
|
25
|
27
|
26
|
|
Cash Taxes Paid |
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
(25)
|
(8)
|
(9)
|
(11)
|
2
|
8
|
9
|
(3)
|
(5)
|
(8)
|
|
Cash from Operating Activities |
(104)
N/A
|
(95)
+9%
|
(121)
-28%
|
(95)
+21%
|
(103)
-8%
|
(112)
-9%
|
(121)
-8%
|
(150)
-24%
|
(158)
-5%
|
(170)
-8%
|
|
Investing Cash Flow | |||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(4)
|
(4)
|
(4)
|
(5)
|
|
Other Items |
102
|
53
|
(213)
|
(346)
|
(460)
|
(467)
|
(126)
|
(51)
|
138
|
199
|
|
Cash from Investing Activities |
102
N/A
|
52
-49%
|
(213)
N/A
|
(346)
-62%
|
(460)
-33%
|
(467)
-2%
|
(130)
+72%
|
(55)
+57%
|
134
N/A
|
194
+45%
|
|
Financing Cash Flow | |||||||||||
Net Issuance of Common Stock |
100
|
395
|
394
|
553
|
553
|
258
|
259
|
1
|
1
|
1
|
|
Cash Paid for Dividends |
(17)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Cash from Financing Activities |
83
N/A
|
394
+375%
|
392
0%
|
553
+41%
|
553
+0%
|
258
-53%
|
259
+0%
|
(0)
N/A
|
0
N/A
|
0
-36%
|
|
Change in Cash | |||||||||||
Net Change in Cash |
81
N/A
|
351
+335%
|
58
-83%
|
111
+92%
|
(11)
N/A
|
(322)
-2 962%
|
7
N/A
|
(206)
N/A
|
(24)
+88%
|
24
N/A
|
|
Free Cash Flow | |||||||||||
Free Cash Flow |
(104)
N/A
|
(95)
+8%
|
(121)
-28%
|
(96)
+21%
|
(103)
-8%
|
(113)
-9%
|
(125)
-11%
|
(154)
-23%
|
(162)
-5%
|
(175)
-8%
|